News

Latest updates and highlights

January 2021

Memorandum of Understanding between FDA and NIST, to increase U.S. medical supply chain resilience and advance domestic manufacturing of pharmaceuticals, biopharmaceuticals, and medical devices through adoption of 21st century manufacturing technologies including smart technologies, emerging manufacturing processes, and artificial intelligence and machine learning

January 2023

Press Release: Initiative to benchmark and profile monoclonal antibody and large biomolecule stability